Qiming U.S. Healthcare Fund II, L.P. - Sep 24, 2021 Form 3 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
10%+ Owner
Signature
By: /s/ Mark D. McDade, Managing Partner of Qiming U.S. Healthcare GP II, LLC, General Partner of Qiming U.S. Healthcare Fund II, L.P.
Stock symbol
JSPR
Transactions as of
Sep 24, 2021
Transactions value $
$0
Form type
3
Date filed
10/1/2021, 04:08 PM
Previous filing
Aug 2, 2021
Next filing
Apr 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding JSPR Voting Common Stock 5.85M Sep 24, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). The general partner of Qiming is Qiming U.S. Healthcare GP II, LLC ("Qiming GP"). Gary Rieschel and Mark McDade are the managing partners of Qiming GP. Each of Qiming GP, Mr. Rieschel and Mr. McDade may be deemed to beneficially own the shares owned by Qiming.